When is the KESETT trial expected to be completed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

KESETT Trial Completion Timeline

The KESETT trial completion date is not explicitly stated in the available evidence, but based on the study design described, it appears to be an ongoing or planned trial without a specified end date in the provided materials. 1

What We Know About KESETT

The KESETT study is described as a three-armed, Bayesian adaptive randomized trial comparing two doses of ketamine plus levetiracetam to levetiracetam alone for treating benzodiazepine-refractory status epilepticus 1. The trial design features:

  • Primary outcome assessment at 60 minutes post-intervention
  • An ordinal outcome scale ranging from 1 (improving consciousness and seizure cessation) to 5 (life-threatening event/death)
  • Bayesian adaptive methodology with response-adaptive randomization

Key Limitations

The evidence provided 1 discusses the statistical methodology and design of the KESETT trial but does not include:

  • Estimated enrollment completion date
  • Primary completion date
  • Study completion date
  • Current recruitment status
  • Sample size targets

This appears to be a methodological paper describing the trial's analytical approach rather than a trial registration or protocol paper that would typically contain timeline information.

Where to Find Completion Information

To obtain the actual completion date for KESETT, you would need to:

  • Check ClinicalTrials.gov or other trial registries using "KESETT" or "ketamine levetiracetam status epilepticus" as search terms
  • Contact the study investigators directly
  • Review the full trial protocol if publicly available

The statistical methodology paper 1 was published in 2023, suggesting the trial was in planning or early stages at that time, but no definitive timeline is provided in the available evidence.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.